| Acetal–PEG–b–PBLG | Acetal–poly(ethylene glycol)–b–poly(γ-benzyl l-glutamate) |
| (AC2)-DOPA–NCA | Di-O,O’-acetyl-l-l-3,4 dihydroxyphenylalanine-N-carboxyanhydride |
| ACN | Acetonitrile |
| ADR | Adriamycin |
| AFM | Atomic Force Microscopy |
| AIBN | 2,2’-Azo-bis(isobutyronitrile) |
| Asp(OBzl)–NCA | β-Benzyl l-aspartate N-carboxy-anhydride |
| ATPEG | Poly(ethylene glycol)-bis-amine |
| ATRP | Atom Transfer Radical Polymerization |
| BLA | β-Benzyl–l-aspartate |
| BLG | γ-Benzyl–l-glutamate |
| BIED | Bis(β-isocyanatoethyl) disulfide |
| Bn-His | N-im-benzyl-l-histidine |
| Boc-l-His–(Bn)–OH | N-α-t-Butyloxycarbonyl-N-im-benzyl-l-histidine |
| BODIPY-Br2 | 3,7-Dibromo-2,8-di(4-methoxyphenyl)-11-trifluoromethyl-dithieno [2,3-b]-[3,2-g0-5,5-difluoro-5-bora-3a,4a-diaza-s-indacene |
| bpy | 2,2’-Bipyridyl |
| CDDP, cisplatin | cis-Diamminedichlo-platinum |
| Ce 6 | Clorin e6 |
| CMC | Critical Micelle Concentrations |
| CP | Cloud Point |
| CR–CAs | Cancer–recognizable contrast agents |
| DCC | N,N’-Dicyclohexylcarbodiimide |
| DCM | Dicyclohexylcarbodiimide |
| DCU | Dicyclohexylurea |
| DDACT | S-1-dodecyl-S’-(α,α’-dimethyl-α’’-acetic acid) Trithiocarbonate |
| DEX | Dexamethasone |
| Dh | Hydrodynamic diameter |
| DHA | Dehydroascorbic acid |
| DHAA | Dehydroascorbic acid |
| DHPE | N-(5-dimethylaminoapthalene-1-sulfonyl)-1,2,-dihexadecanoyl-Sn-glycero-3-phosphoethanolamine |
| DIC | N,N’-diisopropylcarbodiimide |
| DIPEA | Diisopropylethylamine |
| DLC | Drug Loading Content |
| DLE | Drug Loading Efficiency |
| DLS | Dynamic Light Scattering |
| DMAc | N,N’-Dimethyl acetamide |
| DMAP | 4-(Dimethylamino)pyridine |
| DMAPMA | N,N-dimethylaminopropyl methacrylamide |
| DMF | N,N-Dimethyloformamide |
| DMA | 2,3-Dimethylmaleic anhydride |
| DMAP | 4-Dimethylaminopyridine |
| DMPP | Dimethylphenylphosphine |
| DMSO | Dimethylosulfoxide |
| DOX | Doxorubicin |
| DOX·HCl | Doxorubicin hydrochloride |
| DOX-NP | DOX–nanoparticles |
| DOTA | 1,4,7,10-tetraazacyclododecane–1,4,7,10–tetraacetic acid |
| DOTA/m | DOTA–functionalized polymeric micelles |
| DP | Degree of Polymerization |
| DTT | 1,4-Dithiothreitol |
| DTDP | 3,3′-Thiodipropionic acid |
| DTPA | Diethylene triamine pentaacetic |
| DTSSP | 3,3’-dithiobis(sulfosuccinimidyl propionate) |
| DTX | Docetaxel |
| DTX–CLPMs | (DTX) loaded core-cross-linked polymer micelles |
| DTX–NPM | DTX-loaded non-crosslinked |
| EG2–Glu–NCA | ethyl diglycol L-glutamate N-carboxyanhydride |
| FA | Folic acid |
| FBS | Fetal bovine serum |
| Fmoc | Fluorenylmethyloxycarbonyl chloride |
| FT-IR | Fourier Transform Infrared Spectroscopy |
| GA | Glycyrrhetinic acid |
| GA–PEG–NH2 | Glycyrrhetinic acid-modified poly(ethylene glycol)–bis-amine |
| GSH | Glutathione |
| HA | Hyaluronic acid |
| HBr-HAc | Hydrobromic acid-acetic acid |
| HCC | Hepatocellular carcinoma |
| HDI | Hexamethylenediisocyanate |
| 1H NMR | Proton Nuclear Magnetic Resonance |
| HPLC | High Pressure Liquid Chromatography |
| Hyd | Hydrazine |
| ICG | Indocyanine green |
| IC50 | The half maximal inhibitory concentration |
| ICP–MS | Inductively coupled plasma mass spectrometry |
| ICP–OES | Inductively coupled plasma–optical emission spectrometry |
| Ins-CAs | pH-insensitive cancer–recognizable contrast agents |
| LA | Lipoic acid |
| Lac-N3 | Lactobionolamidopropylazide |
| LCST | Low critical solution temperature |
| LEV | Levulinic acid |
| L-Phe | l-phenylalanine |
| LLA | l-lactic acid |
| Lys(Z) | N6-carbobenzyloxy–l-lysine |
| MALDI-TOF MS | Matrix-assisted laser desorption/ionization Time of Flight Mass Spectrometry |
| MDR | Multidrug Resistance |
| MEO2MA | 2-(2-methoxyethoxy)ethyl |
| MEO3MA | 2-(2-(2-methoxyethoxy)ethoxy)ethyl methacrylate |
| mPEG–b–pAsp(DA) | Monomethoxy poly(ethylene glycol)–b–decylamine-grafted poly(l-aspartic acid) |
| mPEG–b–P(Glu-co-Phe) | Poly(ethyleneglycol)–b–poly(l-glutamic acid-co-l-phenylalanine) |
| mPEG–CHO | Methoxy poly(ethylene glycol)-aldehyde |
| mPEG–NH2 | α-Μethoxy-ω-amine-poly (ethylene glycol) |
| (mPEG)2–b–PBG | (Μethoxy-poly(ethylene glycol))2-block-poly(g-benzyl-l-glutamate) |
| (mPEG)2–b–PGA | (Μethoxy-poly(ethylene glycol))2–b–poly(l-glutamic acid) |
| mPEG–PA | Methoxy-poly(ethylene glycol)-block-poly(aspartamide) |
| mPEG–PAlEA | Methoxy-poly(ethylene glycol)–poly(aldehyde ethyl aspartamide) |
| mPEG–PAmEA | Methoxy-poly(ethylene glycol)-block-poly(amino ethyl l-aspartamide) |
| mPEG–PBLG–SS–DTX | Conjugates poly(ethylene glycol)-poly(γ-benzyl l-glutamate)-disulfide-docetaxel |
| mPEG-g-PLL–b–Phe | Methoxypolyethylene glycol-graft-poly(l-lysine)-block-poly(l-phenylalanine) |
| mPEG–PPDA | Methoxy-poly(ethylene glycol)-block-poly(propanediol l-aspartamide) |
| Mn | Average molecular weight |
| MRI | Magnetic Resonance Imaging |
| MWCO | Molecular Weight Cut-Off |
| NaBH3CN | Sodium cyanoborohydride |
| NaN3 | Sodium azide |
| NBS | N-Boc-serinol |
| NCA | N-carboxyanhydride |
| NHS | Hydroxysuccinimide |
| NIPAM | N-Isopropylacrylamide |
| NIR | Near Infrared |
| NIRF | Near-infrared fluorescent |
| NMAm | N-methylol acrylamide |
| NMP | N-methyl pyrrolidone |
| NOTA | 1,4,7-Triazacyclononane-N,N’,N’’-triacetic acid |
| NPs | Nanoparticles |
| N3-PEG-NH2 | α-azide-ω-amino-poly(ethylene glycol) |
| PA | Photoacoustic |
| PAMA | Poly(2-aminoethyl methacrylate) |
| (PGAH–b–PDMAPMA)3-g-PEG | [poly(l-glutamic acid γ-hydrazide)–b–poly(N,N-dimethylaminopropyl methacrylamide]3-g-poly(ethylene glycol) |
| PBS | Phosphate-buffered saline |
| PBLG–b–PMPC | Poly(γ-benzyl–l-glutamate)–block–poly(2-Methacryloyloxyethyl phosphorylcholine) |
| PC-g-PEG | Poly(cysteine)-g-poly(ethylene glycol) |
| PDI | Polydispersity |
| PDT | Photodynamic therapy |
| PEG | Poly(ethylene glycol) |
| PEG–PAA | Poly(ethylene glycol)–b–poly(amino acids) |
| PEG–b–P(d-Leu) | Poly(ethyleneglycol)–b–poly(d-Leucine) |
| PEG–p(HYD) | Poly(ethyleneglycol)–b–poly(aspartate hydrazide) |
| PEG–b–p(Asp) | Poly(ethylene glycol)–b–poly(β-benzyl-l-aspartate) |
| PEG–b–PBLG | Poly(ethylene glycol)–b–poly(γ-benzyl-l-glutamate) |
| PEG–b–PLL–b–PLLeu | Poly(ethylene glycol)–b–poly(l-lysine)-b-poly(l-leucine) |
| PEG–b–p(l-His) | Poly(ethylene glycol)–b–poly(l-histidine) |
| PEG–b–p(l–LA)–DTPA–Gd | Poly(ethylene glycol)–b–poly(l-lactic acid)- Diethylenetriaminopentaacetic acid dianhydride- gadolinium chelate |
| PEG–b–P(l-Leu) | Poly(ethylene glycol)–b–poly(l-Leucine) |
| PEG–b–PGlu(EDA–LA)–b–PPhe | Poly(ethylene glycol)–b–poly(γ-benzyl–l-glutamate)–b–poly(l-phenylalanine) |
| PGLG | Poly(galactosylated) l-glutamate |
| Phe | Phenylalanine |
| PLGA | Poly(d,l-lactide-co-glycolide) |
| PLGA–b–PPhe | Poly(glutamic acid)–b–polyphenylalanine |
| PLG NCA | γ-Propargyl-l-glutamate methacrylate |
| PLGA | Poly(d,l-lactide-co-glycolide) |
| PLLZ | Poly(Nε-carbobenzyloxy-l-lysine) |
| PMLG | Poly(oligo(ethylene glycol)l-glutamate |
| PNBC | poly(S-(O-nitrobenzyl)-d,l-cysteine) |
| PPLG | Poly(γ-propargyl–l-glutamate) |
| [p(NIPAM)–b–p(His)] | Poly(N-isopropylacrylamide)–b–poly(l-histidine) |
| POEGMA | Poly[oligo(ethylene glycol) methacrylate] |
| PS | Photosensitizer |
| PTT | Photothermal therapy |
| PTX | Paclitaxel |
| QUR | Quercetin |
| RAFT | Reversible addition fragmentation chain transfer polymerization |
| RAP | Rapamycin |
| RES | Resveratrol |
| ROP | Ring Opening Polymerization |
| RP–HPLC | Reversed-phase high pressure liquid chromatography |
| SA | Succinyl chloride |
| SCLM | Shell cross-linking micelles |
| SEC | Size exclusion chromatography |
| SGC | Scirrhous gastric cancer |
| siRNA | Small interfering RNA |
| SPPCL–b–PZLLs | Poly(ε-caprolactone)–b–poly(ε-benzyloxycarbonyl–l-lysine) |
| TAEA | Tri(2-aminoethyl) amine |
| TEA | Triethylamine |
| TEM | Transmission electron microscopy |
| TFA | Trifluoroacetic acid |
| THF | Tetrahydrofuran |
| VE | Vitamin E |
| VE-NH2 | Vitamin E-ethylenediamine |
| VEOEG | Vitamin E-Oligo(methyl diglycol l-glutamate) |
| Z-L-Lys NCA | Nε-benzyloxycarbonyl–l-lysine N-carboxyanhydride |
| 3PO | 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one |
| 4-NC | 4-Nitrophenyl chloroformate |
| γ-Bzl–l-Glu-NCA | 5-Benzyl-l-glutamate-N-carboxyanhydride |